Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group - Rudick, RA; Cookfair, DL; Simonian, NA (J Neuroimmunol, 1999)
et al.